Avalanche Biotechnologies

The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
Avalanche shares continute to fall off a cliff as company ditches eye drug trial
BioPharma Dive
Fri, 08/14/15 - 10:10 am
Avalanche Biotechnologies
AVA-101
wet age-related macular degeneration
Avalanche Biotech's stock loses half its value after trial results raise concerns
Marketwatch
Tue, 06/16/15 - 09:11 am
Avalanche Biotechnologies
wet age-related macular degeneration
AVA-101
Biotech's R&D Talent Opportunity
Forbes
Mon, 04/6/15 - 05:38 pm
R&D
Avalanche Biotechnologies
Biotech's next buzz: Gene therapy?
CNBC
Tue, 03/31/15 - 03:59 pm
biotech
gene therapy
Spark Therapeutics
Biomarin
Avalanche Biotechnologies
2014's most successful biotech IPOs
Fierce Biotech
Mon, 10/13/14 - 08:03 am
IPOs
biotech
Ultragenyx
ZS Pharma
Auspex Pharmaceuticals
Avalanche Biotechnologies
SAGE Therapeutics
Kite Pharma
Otonomy
Zafgen
ProQR
Radius Health
Two Promising Gene Therapy Stocks Tackling Eye Disease
TheStreet.com
Tue, 09/9/14 - 10:15 am
Applied Genetic Technologies
Avalanche Biotechnologies
eye disease
Gene therapy biotech Avalanche banks $102M in an up-sized IPO
Fierce Biotech
Thu, 07/31/14 - 10:04 am
gene therapy
Avalanche Biotechnologies
IPOs
Monday’s Top Health Care Stories: Pfizer, Auxilium, and Regeneron
Motley Fool
Mon, 05/5/14 - 10:15 am
Pfizer
Auxilium
Regeneron
earnings
Avalanche Biotechnologies